Andrew H Baker Selected Research

Squamous Cell Carcinoma (Epidermoid Carcinoma)

6/2002	Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3.
1/2002	Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew H Baker Research Topics

Disease

12	Neoplasms (Cancer) 04/2014 - 01/2002
10	Hypoxia (Hypoxemia) 01/2023 - 06/2003
9	Atherosclerotic Plaque (Atheroma) 10/2023 - 05/2006
9	Infections 02/2021 - 02/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2002
8	Pulmonary Arterial Hypertension 01/2022 - 04/2010
7	Fibrosis (Cirrhosis) 01/2024 - 08/2006
7	Vascular System Injuries 01/2024 - 11/2011
7	Inflammation (Inflammations) 10/2023 - 08/2006
7	Atherosclerosis 01/2022 - 08/2003
7	Vascular Remodeling 01/2019 - 06/2003
6	Stroke (Strokes) 08/2011 - 08/2005
5	Myocardial Infarction 01/2023 - 11/2019
5	Ischemia 01/2022 - 01/2003
5	Hypertension (High Blood Pressure) 10/2020 - 10/2010
5	Pulmonary Hypertension 01/2017 - 06/2003
4	Infarction (Infarctions) 01/2024 - 02/2007
4	Wounds and Injuries (Trauma) 12/2023 - 02/2002
4	Neoplasm Metastasis (Metastasis) 04/2014 - 11/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 10/2012
3	Heart Failure 01/2021 - 08/2006
2	COVID-19 01/2024 - 09/2022
2	Leukemia 01/2023 - 01/2016
2	Heart Diseases (Heart Disease) 01/2023 - 03/2012
2	Cardiomyopathies (Cardiomyopathy) 01/2020 - 11/2019
2	Hyperplasia 01/2019 - 08/2013
2	Vascular Diseases (Vascular Disease) 01/2018 - 09/2013
2	Thrombocytopenia (Thrombopenia) 01/2017 - 09/2012
2	Lung Neoplasms (Lung Cancer) 11/2016 - 09/2006
2	Neointima 05/2015 - 09/2011
2	Carcinoma (Carcinomatosis) 04/2014 - 09/2012
2	Ureteral Obstruction 12/2013 - 08/2011
2	Melanoma (Melanoma, Malignant) 04/2003 - 06/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2002 - 01/2002
1	Albuminuria 01/2024
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2023
1	Arteriosclerosis 01/2023
1	Calcinosis 01/2022
1	Left Ventricular Dysfunction 01/2022

Drug/Important Bio-Agent (IBA)

22	MicroRNAs (MicroRNA)IBA 12/2023 - 04/2010
11	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2002
9	Tissue Inhibitor of Metalloproteinase-3IBA 01/2018 - 01/2002
8	RNA (Ribonucleic Acid)IBA 01/2024 - 06/2015
8	CytokinesIBA 02/2021 - 08/2003
7	Long Noncoding RNAIBA 01/2023 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2002
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2021 - 08/2003
4	IntegrinsIBA 01/2019 - 10/2010
4	Peptides (Polypeptides)IBA 04/2014 - 11/2003
4	Tissue Inhibitor of Metalloproteinase-1IBA 05/2006 - 01/2003
3	Angiotensin IIIBA 01/2024 - 01/2020
3	CollagenIBA 01/2022 - 02/2005
3	Semaxinib (SU5416)IBA 01/2022 - 07/2014
3	Death Domain ReceptorsIBA 01/2018 - 04/2003
3	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2015 - 08/2011
3	Metalloproteases (Metalloproteinases)IBA 12/2013 - 02/2007
3	Apolipoproteins E (ApoE)IBA 02/2008 - 05/2006
3	Peptide Hydrolases (Proteases)FDA Link 08/2006 - 02/2002
2	salicylhydroxamic acid (SHAM)IBA 01/2024 - 01/2022
2	CalciumIBA 01/2022 - 11/2019
2	GadoliniumIBA 01/2022 - 01/2020
2	Angiotensin-Converting Enzyme 2IBA 02/2021 - 04/2009
2	Messenger RNA (mRNA)IBA 01/2019 - 03/2002
2	Therapeutic UsesIBA 01/2018 - 09/2006
2	Lipoproteins (Lipoprotein)IBA 12/2017 - 08/2003
2	Biomarkers (Surrogate Marker)IBA 04/2016 - 04/2013
2	Serotonin (5 Hydroxytryptamine)IBA 06/2015 - 08/2012
2	Caspase 3 (Caspase-3)IBA 07/2014 - 04/2003
2	DisintegrinsIBA 12/2013 - 01/2013
2	Interleukin-6 (Interleukin 6)IBA 05/2013 - 02/2002
2	Caspase 8 (Caspase-8)IBA 02/2011 - 04/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2010 - 07/2010
2	MonocrotalineIBA 04/2010 - 06/2003
2	ApolipoproteinsIBA 03/2007 - 05/2006
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 02/2007 - 02/2002
2	Bromodeoxyuridine (BrdU)IBA 02/2007 - 02/2005
2	Tissue Inhibitor of Metalloproteinase-2IBA 12/2006 - 05/2006
2	Tissue Inhibitor of MetalloproteinasesIBA 05/2006 - 06/2002
2	Pancreatic Elastase (Elastase)IBA 06/2003 - 02/2002
1	Purinergic P2X7 ReceptorsIBA 01/2024
1	Colchicine FDA LinkGeneric 10/2023
1	Vascular Endothelial Growth Factor CIBA 01/2023
1	Propranolol (Inderal)FDA LinkGeneric 01/2023
1	Oxygen (Dioxygen)IBA 01/2022
1	TroponinIBA 01/2022
1	CholesterolIBA 01/2022
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2022
1	Troponin IIBA 01/2022
1	FluoridesIBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Histones (Histone)IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Hydroxyproline (4 Hydroxyproline)IBA 10/2020

Therapy/Procedure

13	Therapeutics 01/2020 - 06/2002
6	Stents 10/2016 - 11/2011
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 10/2012
2	Oral Administration 12/2013 - 11/2011
1	Ligation 01/2022
1	Immunomodulation 01/2022